BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17116187)

  • 1. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria.
    Wotherspoon F; Laight DW; Browne DL; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
    Diabet Med; 2006 Dec; 23(12):1350-6. PubMed ID: 17116187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oral folic acid upon plasma homocysteine, endothelial function and oxidative stress in patients with type 1 diabetes and microalbuminuria.
    Wotherspoon F; Laight DW; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
    Int J Clin Pract; 2008 Apr; 62(4):569-74. PubMed ID: 18248393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.
    Ozdemir G; Ozden M; Maral H; Kuskay S; Cetinalp P; Tarkun I
    Ann Clin Biochem; 2005 Mar; 42(Pt 2):99-104. PubMed ID: 15829117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C.
    Antoniades C; Tousoulis D; Tountas C; Tentolouris C; Toutouza M; Vasiliadou C; Tsioufis C; Toutouzas P; Stefanadis C
    Diabet Med; 2004 Jun; 21(6):552-8. PubMed ID: 15154938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant status and lipid peroxidation end products in patients of type 1 diabetes mellitus.
    Peerapatdit T; Likidlilid A; Patchanans N; Somkasetrin A
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S141-6. PubMed ID: 17718255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipid peroxidation and antioxidiant nutrients in type 2 diabetic patients.
    Peerapatdit T; Patchanans N; Likidlilid A; Poldee S; Sriratanasathavorn C
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S147-55. PubMed ID: 17718256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total plasma homocysteine is associated with hypertension in Type I diabetic patients.
    Neugebauer S; Tarnow L; Stehouwer C; Teerlink T; Baba T; Watanabe T; Parving HH
    Diabetologia; 2002 Sep; 45(9):1315-24. PubMed ID: 12242465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients.
    Cassone Faldetta M; Laurenti O; Desideri G; Bravi MC; De Luca O; Marinucci MC; De Mattia G; Ferri C
    Diabetologia; 2002 Aug; 45(8):1120-7. PubMed ID: 12189442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk "Golden Years" type 1 diabetes mellitus cohort.
    Prior SL; Tang TS; Gill GV; Bain SC; Stephens JW
    Metabolism; 2011 Feb; 60(2):173-9. PubMed ID: 20188385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus.
    Ozmen B; Ozmen D; Turgan N; Habif S; Mutaf I; Bayindir O
    Ann Clin Lab Sci; 2002; 32(3):279-86. PubMed ID: 12175091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus.
    Ibrahim HA; El-Meligi AA; Abdel-Hamid M; Elhendy A
    Med Sci Monit; 2004 Mar; 10(3):CR85-9. PubMed ID: 14976459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.
    Yu Y; Suo L; Yu H; Wang C; Tang H
    Diabetes Res Clin Pract; 2004 Aug; 65(2):95-104. PubMed ID: 15223221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced plasma total homocysteine concentrations in Type 1 diabetes mellitus is determined by increased renal clearance.
    Veldman BA; Vervoort G; Blom H; Smits P
    Diabet Med; 2005 Mar; 22(3):301-5. PubMed ID: 15717878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes Adrenomedullin and vascular risk factors in Type 1 DM.
    García-Unzueta MT; Berrazueta JR; Pesquera C; Obaya S; Fernández MD; Sedano C; Amado JA
    J Diabetes Complications; 2005; 19(3):147-54. PubMed ID: 15866060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione and glutathione peroxidase in type 1 diabetic patients.
    Likidlilid A; Patchanans N; Poldee S; Peerapatdit T
    J Med Assoc Thai; 2007 Sep; 90(9):1759-67. PubMed ID: 17957916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone and IGF-I in diabetic children with and without microalbuminuria.
    Verrotti A; Cieri F; Petitti MT; Morgese G; Chiarelli F
    Diabetes Nutr Metab; 1999 Aug; 12(4):271-6. PubMed ID: 10782753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.